Endurance Training in Young Persons With Cerebral Palsy; Evaluation of Training Method and Effect

Cerebral Palsy Clinical Trial

Official title:

Enthusiasm - Sweat - Satisfaction! In Youngster With CP

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00965133
• Other study ID #: Shdir-08/4914
• Status: Completed
• Phase: N/A
• First received: August 24, 2009
• Last updated: June 10, 2013
• Start date: September 2009
• Est. completion date: February 2011

Study information

• Verified date: June 2013
• Source: Reidun Lauglo
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Directorate of Health
• Study type: Interventional

Clinical Trial Summary

The hypotheses of the study are that children / youth with CP will by possibly use of technical aids be able to perform high intensity endurance training by walking / running on a treadmill, and that this training will improve their health by increased aerobic capacity and quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: February 2011
• Est. primary completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 10 Years to 17 Years

Eligibility

Inclusion Criteria:

• Person with CP, GMFCS-level I-IV, age 10-17 years

• Living in Mid-Norway

• Wants to increase his / her level of physical activity

Exclusion Criteria:

• Completes less than 75% of the total number of training sessions

• Not able to complete the testing and training procedures due to sickness, injury or other physical and psychological conditions

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cerebral Palsy

Intervention

Other:
• Endurance training intervention
High intensive interval training of walking / running on treadmill for 1 1/2 - 4 minute,repeated minimum 4 times, at an intensity equalling at least 80% of maximal heart frequency. Performed 2-5 times per week for 4-8 weeks, totally 24 sessions.

Locations

Country	Name	City	State
Norway	Rosenborgklinikken	Trondheim

Sponsors (4)

Lead Sponsor	Collaborator
Reidun Lauglo	Norwegian University of Science and Technology, Rosenborgklinikken, St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Aerobic capacity		Sept. 2009 - april 2010	No
Secondary	Quality of life		Sept. 2009 - April 2010	No